OutSee
To add a bio or update company history, please click update information.
News from OutSee
OutSee
24 Jun 2025
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.
OutSee
12 Jan 2026
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
OutSee
- Life Sciences
- Cambridge, United Kingdom
- £4.3m
- outsee.co.uk
- Update Information
More venture news
- 3 Jun 2026
ApohaApoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
EquityLife Sciences - 2 Jun 2026
IMU BiosciencesIMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
Series ALife Sciences - 28 May 2026
PercepticPerceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
SeedLife Sciences
